Set them on their journey to better diabetes management
Resources and guidance to help pharmacists and pharmacy assistants empower customers with Dexcom ONE real-time Continuous Glucose Monitoring (rtCGM) technology. Now available on prescription for people with diabetes on insulin and those meeting certain criteria.1-3
Standard of care is changing
NICE (National Institute for Health and Care Excellence) now recommends that people with type 1 diabetes are offered a choice of glucose sensor, including rtCGM.1 Children and young people with type 1 diabetes should be offered rtCGM.2
For people with type 2 diabetes the recommendation is that rtCGM can be considered as an alternative to intermittent scanning (isCGM).3
The Dexcom ONE sensors last up to 10 days and can be ordered by prescription on the NHS, if the customer is eligible as per local criteria.‡ The transmitter is re-usable and has a 3-month battery life.
Diabetes management made easier with Dexcom ONE
Dexcom ONE rtCGM is smart, effective,§,4,5 and easy to use.||,6 The diabetes management tool continuously measures glucose levels and displays them on a smartphone† or optional receiver¶ without finger pricks.*
Compared to a single Blood Glucose Monitoring (BGM) reading, Dexcom ONE allows people to see their glucose levels and where they are heading, enabling confident treatment decisions.*,†,||,7
Experience the Dexcom difference
No finger pricks*
No calibrations or scanning required
Glucose readings in real time on a smart device† or receiver¶
Confident treatment decisions even when glucose is changing rapidly
Glucose trends and patterns, night and day with Dexcom Clarity**
Dexcom CGM system use is proven to lower HbA1c and increase time in range††
90% of first-time customers intend to keep using Dexcom12
Dexcom is here to support you
Need additional support?
Find frequently asked questions for pharmacy.
Email our specialist pharmacy support team.
*If your glucose alerts and readings from Dexcom ONE do not match symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions.
†For a list of compatible smart devices, please visit www.dexcom.com/compatibility.
‡Local prescribing policies may vary.
§Results obtained with a prior generation of a Dexcom rtCGM system.
||Results obtained with Dexcom G6 study, which uses the same applicator and sensor (and algorithm) as Dexcom ONE.
¶A receiver can be acquired as an optional display device.
**Patient must first sync their Dexcom ONE data with the Dexcom Clarity app and consent to share their data with their healthcare provider. An internet connection
is required for patients to send their glucose data to Dexcom Clarity via a compatible smart device: dexcom.com/compatibility.
††Time in range was defined as 3.9 - 10.0 mmol/L.
1 Type 1 diabetes in adults: diagnosis and management. NICE guideline [NG17]. https://www.nice.org.uk/guidance/ng17.
2 Diabetes (type 1 and type 2) in children and young people: diagnosis and management. NICE guideline [NG18]. https://www.nice.org.uk/guidance/ng18.
3 Type 2 diabetes in adults: management. NICE guideline [NG28]. https://www.nice.org.uk/guidance/ng28.
4 Beck RW, et al. JAMA. 2017;317(4):371-378.
5 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374.
6 Shah VN, et al. Diabetes Technol Ther. 2018;20(6):428-433.
7 Wadwa RP, et al. Diabetes Technol Ther. 2018;20(6):395-402.
8 Dexcom ONE User Guide, 2022.
9 Šoupal, J, et al. Diabetes care. 2020;43(1):37-43.
10 Martens T, et al. JAMA. 2021;325(22):2262-2272.
11 La el L, et al. JAMA. 2020;323(23):2388-2396.
12 Dexcom, Data on file 2022.